Skip to main content
FinSpry Logo
FinSpry
RCEL logo
RCEL
(NASDAQ)
AVITA Medical, Inc.
$4.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

AVITA Medical (RCEL) Stock Price & Financial Analysis

AVITA Medical Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.92 - $4.33
52-Week High$7.43
52-Week Low$3.22
Open$4.12
Volume180.87K
Average Volume (3M)267.15K
Market Cap127.31M
Shares Outstanding30.38M
Price to Sales (P/S)1.93
Price to Book (P/B)-8.32
EV/EBITDA-4.21
Revenue (TTM)71.61M
Net Income (TTM)-48.59M
Free Cash Flow (TTM)-36.16M
EPS (TTM)$-1.74
Profit Margin-67.85%
Operating Margin-59.40%
50-Day MA$4.42
200-Day MA$4.38
52-Week Change-39.72%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About AVITA Medical

What is the current stock price for RCEL?

As of the latest trading session, RCEL stock trades at $4.20. The 52-week range is $3.22–$7.43, with a day range of $3.92–$4.33.

What is the P/E ratio for RCEL?

The P/E ratio (Price-to-Earnings) for RCEL is shown in the Key Statistics section. This valuation metric helps compare AVITA Medical, Inc. to industry peers.

Does RCEL pay dividends?

AVITA Medical does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RCEL?

Based on 2 analysts, the consensus for RCEL is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of RCEL?

AVITA Medical's market capitalization is $127.5M, classifying it as a micro-cap company..